Federal Register notice: FDA classifies blood collection devices for cell-free nucleic acids into Class 2.
GSK says data from two clinical trials showed that depemokimab significantly reduces asthma exacerbations in patients with severe Type 2 inflammation.
FDA removes a partial clinical hold against Rezolutes RZ358 (ersodetug), an investigational drug for treating hypoglycemia caused by congenital hyperi...
FDA clears a Femasys 510(k) for its diagnostic device for checking the fallopian tubes to confirm permanent birth control placement.
The Association for Diagnostics and Laboratory Medicine raises significant concerns regarding the recent FDA final rule on laboratory-developed tests,...
FDA grants Travere Therapeutics full approval for Filspari (sparsentan) for slowing kidney function decline in adults with primary immunoglobulin A ne...
Federal Register notice: FDA seeks comments on an information collection revision entitled Pharmaceutical Distribution Supply Chain; Drug Supply Chain...
Federal Register notice: FDA makes available a draft guidance entitled Incorporating Voluntary Patient Preference Information over the Total Product L...
